Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Gene Symbol: |
PJA1 |
Gene ID: |
64219 |
Uniprot ID: |
PJA1_HUMAN |
Immunogen Region: |
1-240 aa |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-240 of human PJA1 (NP_660095.1). |
Immunogen Sequence: |
MGQESSKPVWPNPTGGYQSN TGRRYGRRHAYVSFRPPTSQ RERIASQRKTNSEVPMHRSA PSQTTKRSRSPFSTTRRSWD DSESSGTNLNIDNEDYSRYP PREYRASGSRRGMAYGHIDS YGADDSEEEGAGPVERPPVR GKTGKFKDDKLYDPEKGARS LAGPPPHFSSFSRDVREERD KLDPVPAARCSASRADFLPQ SSVASQSSSEGKLATKGDSS ERERREQNLPARPSRAPVS |
Tissue Specificity | Expressed in various regions of the brain including the cerebellum, cerebral cortex, medulla, occipital pole, frontal lobe, temporal lobe and putamen. Highest levels in the cerebral cortex. |
Post Translational Modifications | Substrate for E2-dependent ubiquitination. |
Function | Has E2-dependent E3 ubiquitin-protein ligase activity. Ubiquitinates MAGED1 antigen leading to its subsequent degradation by proteasome. May be involved in protein sorting. |
Protein Name | E3 Ubiquitin-Protein Ligase Praja-1Praja1Ring Finger Protein 70Ring-Type E3 Ubiquitin Transferase Praja-1 |
Database Links | Reactome: R-HSA-983168 |
Alternative Antibody Names | Anti-E3 Ubiquitin-Protein Ligase Praja-1 antibodyAnti-Praja1 antibodyAnti-Ring Finger Protein 70 antibodyAnti-Ring-Type E3 Ubiquitin Transferase Praja-1 antibodyAnti-PJA1 antibodyAnti-RNF70 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance